HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA cosmetic hotline

This article was originally published in The Rose Sheet

Executive Summary

FDA cosmetic hotline: FDA's "rough time line" envisions start-up of the Consumer Cosmetics Adverse Reaction Hotline July. Commencement of the hotline, which was originally scheduled for December ("The Rose Sheet" Nov. 14, p. 1), has been pushed back while FDA works with consumer, physician and industry groups to gain backing for the program. FDA says it has received "strong support" from consumer and physician groups. FDA is threatening to proceed with or without support from the cosmetics industry...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001680

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel